<?xml version="1.0" encoding="UTF-8"?>
<p>Cases with neurological complications have also been reported in patients with MERS-CoV.
 <sup>
  <xref rid="bibr17-1756286420932036" ref-type="bibr">17</xref>
 </sup> Neurological manifestations, such as Bickerstaff’s encephalitis overlapping with Guillain–Barré syndrome, intensive-care-unit-acquired neuropathy, seizures and strokes, both ischemic and haemorrhagic, had all complicated the clinical course of patients with MERS-CoV.
 <sup>
  <xref rid="bibr18-1756286420932036" ref-type="bibr">18</xref>
  <xref rid="bibr19-1756286420932036" ref-type="bibr"/>
  <xref rid="bibr20-1756286420932036" ref-type="bibr"/>–
  <xref rid="bibr21-1756286420932036" ref-type="bibr">21</xref>
 </sup> More severe manifestations occurred in two patients with immune-mediated disorders, precisely one with acute disseminated encephalomyelitis and another with encephalitis.
 <sup>
  <xref rid="bibr21-1756286420932036" ref-type="bibr">21</xref>
 </sup> CSF analysis was performed in the last two cases, but MERS-CoV RT-PCR was negative in both of them.
</p>
